Severe Pulmonary Disease Associated with Electronic-Cigarette-Product Use - Interim Guidance > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

FDA is concentrated on processing focused product samples related to clinical sickness and can analyze samples if there may be sufficient materials to test. It is not identified whether or not the lipid is exogenous (from inhaled materials) or endogenous (from altered lipid metabolism). While this investigation is ongoing and the definitive cause of reported illnesses stays uncertain, individuals should consider not using e-cigarette products. Therefore, the suspected trigger is a chemical exposure.

CDC is working closely with the Food and Drug Administration (FDA) to facilitate assortment of knowledge concerning latest e-cigarette product use among patients and to provide technical help associated to product samples related to patients for chemical analysis of remaining substances or chemicals within the e-cigarettes. The kind, extent, and severity of any chemical-associated sickness may rely upon multiple factors together with the chemical to which the user was uncovered; chemical modifications related to heating, dose, frequency, https://www.vapepossible.com/one-hit-wonder-eliquid-–-the-man-–-100ml-6mg and duration of exposure; product delivery methods; and behaviors and medical circumstances of the user.

The specific behaviors and https://www.vapepossible.com/pod-2500-–-disposable-vape-device-–-cola-slush-ice-–-single-55mg exposures of identified patients have various. CDC employees members have deployed to Illinois and Wisconsin, the primary states that recognized patients, as a part of an epidemiologic assistance investigation to assist with their state investigations and continue to work closely with affected states to characterize the exposures and the extent and https://www.vapepossible.com/nobl-vape-co.-–-prato-–-30ml-0mg development of this illness.

CDC has offered technical help to states and f.r.A.G.Ra.NC.E.rnmn%40.r.Os.P.E.r.Les.C@Pezedium.free.fr has issued a Clinical Action alert by its Clinician Outreach and Communication Activity network on August 16, 2019 (6), and https://www.vapepossible.com/ripe-vapes-synthetic-–-mango-freez-–-60ml-18mg has initiated knowledge collection from states. Investigations in affected states are targeted on describing exposures and the epidemiologic, clinical, https://www.vapepossible.com/pinup-vapors-–-victoria-–-60ml-6mg laboratory, and behavioral characteristics of circumstances. As of August 27, 2019, 215 potential instances of severe pulmonary disease associated with the use of digital cigarette (e-cigarette) products (e.g., devices, liquids, refill pods, and cartridges) had been reported to CDC by 25 state well being departments.

Clinicians ought to consider and deal with for different possible cases of illness (e.